Director Integrated Market Development
ExternalPrepare for this interview
EliteAI-generated questions, company research, and talking points tailored to this role
Benefits
Additional Information
At Tactile Medical, we specialize in developing at-home therapy devices to treat lymphedema, chronic venous insufficiency and respiratory illnesses. Position Summary The Director Integrated Market Development is a newly consolidated role that unifies two previously separate functions - field payer relations and segment market development - into a single accountable leader who owns TCMD's full field ecosystem-building motion. This role is the primary interface between TCMD's upstream strategy (clinical evidence, product positioning, payer coverage policy) and the markets where that strategy must be realized: the clinical accounts, payer systems, and integrated health networks where referral decisions are made and coverage is determined. In practical terms, this leader owns two distinct but interdependent capabilities: the field payer engagement function (structured account plans, air game strategy, and KPI-driven payer relationship management across regional and national payers) and the clinical segment market development and downstream marketing function (HCP ecosystem building, clinical education deployment, and referral development across oncology, vascular/therapy, and respiratory segments). Both functions report through this role. Both are deployed against an analytics-fed targeting model. Both operate as coordinated inputs to the coverage and referral outcomes TCMD's strategic plan requires. This role is the sole commercial conduit through which clinical evidence and economic arguments produced by the Office of Medical Affairs & Health Economics enter field deployment. It does not generate clinical strategy - it receives it from Medical Affairs and the Group Product Category Director and translates it into field execution plans with named accountabilities, defined KPIs, and measurable outcomes. The Director is accountable for execution quality, field discipline, and market access results - not for the upstream evidence or positioning those results depend on. The ideal candidate brings 8-12 years of experience spanning market access, managed care, and field market development in medical devices or related regulated healthcare industries. This individual is equally comfortable in a payer medical director meeting and a clinical account strategy session - and has the organizational discipline to run two distinct field teams as one coordinated function. Accountabilities & Responsibilities Field Payer Access Lead and hold accountable the field payer team establishing defined account plans, engagement KPIs, and a structured air game for prioritized payer targets rather than reactive escalation support for the sales force. Own the field payer targeting model - working with the Director Marketing Analytics & Technology to identify which payers, by geography and product line, represent the highest-leverage coverage expansion or retention opportunities, and deploying field resources against that prioritized list systematically. Build and maintain a payer CRM - structured interaction tracking, contact management, and engagement history for the top 30+ payers, ensuring that payer relationships are institutional rather than individual-dependent and that intelligence from field interactions flows back to the policy team. Coordinate formally with Market Access & Government Affairs team on coverage policy strategy - the field payer team executes the engagement plan; the policy team owns the clinical and contractual arguments. Eliminate the coordination gap that currently leaves the two functions operating without a shared account plan. Coordinate with Strategic Accounts on integrated health system and VA strategy that represent both a payer and a provider relationship - Kaiser, integrated Magnet systems, and similar accounts require a coordinated approach across payer relations and strategic accounts that does not currently exist. Establish and track KPIs for field payer performance: payer engagement frequency by tier, coverage expansion wins, E/I designation reversals supported, and field-generated intelligence contributions per quarter - replacing the current state of no defined measurement with a data-driven accountability structure. Clinical Segment Market Development Lead the segment market development team - four Senior Market Development Managers covering oncology, vascular/therapy, and respiratory segments, plus two Clinical Specialists (Anant Chandler and one TBH) - deploying against an analytics-fed HCP targeting model rather than self-directed relationship maintenance. Build and own the HCP targeting model in partnership with the Sr Director Marketing Analytics & Technology - defining which clinicians, by specialty, geography, and referral potential, represent the highest-opportunity accounts for TCMD's products, and ensuring field activity is concentrated there rather than distributed by historical relationships. Define and manage the AffloVest market development motion as a distinct, resou